Bank of America
AVNR

Bank of America’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Bank of America’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-19,451
Closed -$330K – 8112
2014
Q4 		$330K Sell
19,451
-84,443
-81% -$1.19M ﹤0.01% 4957
2014
Q3 		$1.24M Buy
103,894
+60,321
+138% +$412K ﹤0.01% 3810
2014
Q2 		$246K Buy
43,573
+41,555
+2,059% +$191K ﹤0.01% 5360
2014
Q1 		$7K Sell
2,018
-61,023
-97% -$233K ﹤0.01% 7297
2013
Q4 		$212K Sell
63,041
-11,932
-16% -$49.3K ﹤0.01% 5540
2013
Q3 		$317K Buy
74,973
+48,103
+179% +$228K ﹤0.01% 5038
2013
Q2 		$124K Buy
+26,870
New +$92.4K ﹤0.01% 6028

Bank of America's AVNR Position: Q1 2015 in Review

Bank of America sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 19,451 shares — an estimated $330K sold.

Bank of America first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $1.24M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Bank of America reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Bank of America sold 19,451 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $330K.
  • Bank of America first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Bank of America's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.24M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Bank of America's 13F filing for Q1 2015, filed 15 May 2015.